Diligence memo · auto-generated · as of July 2, 2026

Rapid Genomics Llc

Rapid Genomics Llc looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Rapid Genomics Llc operates in Other, based in GAINESVILLE.

Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Rapid Genomics Llc has raised $300K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $300K on 2015-06-26.

Most recent recorded round closed around 2015-06-26.

Valuation (modeled)modeled

Provath models Rapid Genomics Llc at approximately $6.9M (range $200K–$79M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.86× the median modeled value of Pre-Seed Other companies in 2013–2015 (1650 peers) — value vs value, same stage and era. Within the normal band (86% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 11.0 yr ago; this sector typically re-raises about every 11 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 15% of Other peers (25015 compared).

Modeled value ranks above 32% of those peers.

Closest niche peers: Waterblue IV LLC, Fairway America Fund VI, LLC, LoanTek, Inc., Roosevelt Way Investment, L.P., West Coast Customs Inc.

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Broad sector classification weakens peer comparison.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.